Clinical Trial Update: Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating alpha/beta T and B cell depletion with zoledronic acid for solid tumors; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Soft Part Sarcoma
• Chordoma
• Clear Cell Sarcoma
• Desmoplastic Small Round Cell Tumor
• Neuroblastoma
• Peripheral Nerve Sheath Tumor
• Rhabdomyosarcoma
• Synovial Sarcoma

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: University of Florida | Conditions: Neuroblastoma, Rhabdomyosarcoma | Phase 1, Phase 2 | Status: RECRUITING